← FDA Drug Approvals (Drugs@FDA)
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
NDA · New Drug Application · Sponsor: B BRAUN MEDICAL · Approved 2025-04-03
Drug application
- FDA Application #
NDA206056- Application type
- New Drug Application
- Brand name
- PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
- Generic name
- PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE
- Active ingredients
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- B BRAUN MEDICAL
- Manufacturer
- B. Braun Medical Inc.
- First approval
- 2025-04-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown